Lactic acid bacteria and use thereof

US12115200B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12115200-B2
Application numberUS-201917290516-A
CountryUS
Kind codeB2
Filing dateApr 30, 2019
Priority dateNov 2, 2017
Publication dateOct 15, 2024
Grant dateOct 15, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to Lactobacillus plantarum NK3 and Bifidobacterium longum NK49, which are novel lactic acid bacteria, and, more particularly, to a composition comprising novel lactic acid bacteria that are useful for the prevention or treatment of female menopausal disorders.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for treating a female menopausal disorder comprising administering to a subject in need thereof an effective amount of Bifidobacterium longum NK49 having the accession number KCCM12088P, wherein the subject is a female having a sign of loss of female reproductive function, and wherein the female menopausal disorder is at least one selected from the group consisting of depression, anxiety, obesity, and osteoporosis. 2. The method of claim 1 , wherein the method further comprises administering an effective amount of Lactobacillus plantarum NK3 having the accession number KCCM12089P. 3. The method of claim 1 , wherein the Bifidobacterium longum NK49 having the accession number KCCM12088P comprises a 16S rDNA sequence of SEQ ID NO: 2. 4. The method of claim 2 , wherein Lactobacillus plantarum NK3 having the accession number KCCM12089P comprises a 16S rDNA sequence of SEQ ID NO: 1. 5. The method of claim 1 , wherein the female menopausal disorder is osteoporosis, obesity, or depression. 6. The method of claim 1 , the Bifidobacterium longum NK49 having the accession number KCCM12088P is a live bacterial body thereof, a dead bacterial body thereof, a culture thereof, a lysate thereof, or an extract thereof. 7. The method of claim 2 , the Lactobacillus plantarum NK3 having the accession number KCCM12089P is a live bacterial body thereof, a dead bacterial body thereof, a culture thereof, a lysate thereof, or an extract thereof. 8. The method of claim 2 , wherein a ratio of mixture of Lactobacillus plantarum NK3 having the accession number KCCM12089P and Bifidobacterium longum NK49 having the accession number KCCM12088P is 1:1 to 4:1 CFU.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12115200B2 cover?
The present disclosure relates to Lactobacillus plantarum NK3 and Bifidobacterium longum NK49, which are novel lactic acid bacteria, and, more particularly, to a composition comprising novel lactic acid bacteria that are useful for the prevention or treatment of female menopausal disorders.
Who is the assignee on this patent?
Univ Industry Cooperation Group Kyung Hee Univ, Navipharm Co Ltd
What technology area does this patent fall under?
Primary CPC classification C12N1/20. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).